Skip to main content
OpenTrials

Clinical trial condition

Congenital FXIII Deficiency

Explore clinical trials studying Congenital FXIII Deficiency. Study availability and eligibility vary by location and protocol.

10 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Congenital FXIII Deficiency trial results

Completed

A Study of Safety and Effectiveness of NovoThirteen® (rFXIII) During Treatment of Congenital FXIII Deficiency in Japan

NCT02670213

Conditions
Congenital Bleeding Disorder, Congenital FXIII Deficiency
Locations
  • Nagoya University Hospital_Blood Transfusion Aichi, Japan
  • Gamagori Hospital Gamagori-shi, Aichi, Japan
  • Chugoku Central Hospital Hiroshima, Japan
  • Kure Medical Center and Chugoku Cancer Center Kure-shi, Hiroshima, Japan
View Trial Details
Completed

Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational Study

NCT01862367

Conditions
Congenital Bleeding Disorder, Congenital FXIII Deficiency
Locations
  • Novo Nordisk Investigational Site Orange, California, United States
  • Novo Nordisk Investigational Site Tampa, Florida, United States
  • Novo Nordisk Investigational Site Atlanta, Georgia, United States
  • Novo Nordisk Investigational Site Detroit, Michigan, United States
View all 17 locations
View Trial Details
Completed

Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725

NCT00978380

Conditions
Congenital Bleeding Disorder, Congenital FXIII Deficiency
Locations
  • Novo Nordisk Investigational Site Orange, California, United States
  • Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
  • Novo Nordisk Investigational Site Tampa, Florida, United States
  • Novo Nordisk Investigational Site Atlanta, Georgia, United States
View all 34 locations
View Trial Details
Completed

Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit Deficiency

NCT01230021

Conditions
Congenital Bleeding Disorder, Congenital FXIII Deficiency
Locations
  • Novo Nordisk Investigational Site Boston, Massachusetts, United States
  • Novo Nordisk Investigational Site Detroit, Michigan, United States
  • Novo Nordisk Investigational Site Minneapolis, Minnesota, United States
  • Novo Nordisk Investigational Site Columbus, Ohio, United States
View Trial Details
Completed

Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency

NCT00713648

Conditions
Congenital Bleeding Disorder, Congenital FXIII Deficiency
Locations
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Orange, California, United States
  • Novo Nordisk Investigational Site Tampa, Florida, United States
  • Novo Nordisk Investigational Site Atlanta, Georgia, United States
View all 35 locations
View Trial Details

Related conditions